Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03

FDA recall notice · announced August 22, 2018 · Lupin Pharmaceuticals

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03

Reason for recall

Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.

Notes

Distribution: Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.
Lot/code information: Lot #: H800414, Exp. 12/2019
Quantity: 11,706 bottles
Status: Terminated
Products in this recall event:
- Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03 (D-1077-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.